title: Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
authors.forename: Jochem W
authors.initials: JW
authors.lastname: van Werkum
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Topcu
authors.forename: Sonja
authors.initials: S
authors.lastname: Postma
authors.forename: Johannes C
authors.initials: JC
authors.lastname: Kelder
authors.forename: Christian M
authors.initials: CM
authors.lastname: Hackeng
authors.forename: Jurrien M
authors.initials: JM
authors.lastname: ten Berg
authors.forename: Freek W A
authors.initials: FW
authors.lastname: Verheugt
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use*; D000077144:Clopidogrel; D015331:Cohort Studies; D003324:Coronary Artery Disease / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D010979:Platelet Function Tests; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin